Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Meridian Bioscience Inc. - Common Stock (NQ: VIVO )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Meridian Bioscience Inc. - Common Stock

< Previous 1 2 3 4 Next >
Cannabis Stock Gainers And Losers From May 19, 2022
GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 7.42% at $0.99 
Via Benzinga
Marijuana Stock Movers For May 9, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 9.00% at $1.09 
Via Benzinga
Meridian Bioscience's Q2 Revenues Increase 30% To $111M, Highest In Company History
Via Benzinga
Why Meridian Bioscience's Shares Are Rising Today?
Meridian Bioscience Inc (NASDAQ: VIVO) has posted  
Via Benzinga
Meridian Bioscience: Q2 Earnings Insights
Meridian Bioscience (NASDAQ:VIVO) reported its Q2 earnings results on Friday, May 6, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 6, 2022
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion. 
Via Benzinga
Cannabis Stock Movers For May 5, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.62% at $0.01 
Via Benzinga
Meridian Bioscience's Earnings: A Preview
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Meridian... 
Via Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 4, 2022
GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 15.71% at $3.24 
Via Benzinga
Marijuana Stock Movers For April 26, 2022
GAINERS: LOSERS: Leviathan Natural Prods (OTC:LVCNF) shares closed down 13.22% at $0.66 
Via Benzinga
Cannabis Stock Gainers And Losers From April 22, 2022
GAINERS: MariMed (OTC:MRMD) shares closed up 5.59% at $0.72 
Via Benzinga
Cannabis Stock Gainers And Losers From April 7, 2022
GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 15.34% at $8.42 
Via Benzinga
Meridian Bioscience Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q1, Meridian Bioscience (NASDAQ:VIVO) earned $15.34 million, a 130.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $88.34 million... 
Via Benzinga
Bull of the Day - Meridian Bioscience (VIVO)
Meridian Bioscience is a $1 billion provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases. 
Via Talk Markets
Marijuana Stock Movers For March 16, 2022
GAINERS: MGC Pharmaceuticals (OTC: 
Via Benzinga
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers
GAINERS: Nine Energy Service (NYSE: 
Via Benzinga
Sail Through the Choppy Market With These 4 Low-Beta Stocks
Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions. 
Via Talk Markets
FingerMotion (Nasdaq: FNGR) Looks To Jump On Continued Chinese Smartphone Growth With New Products
Photo by 张 嘴 on Unsplash 
Via Benzinga
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. 
Via Investor's Business Daily
Meridian Bioscience: Q1 Earnings Insights
  Meridian Bioscience (NASDAQ:VIVO) reported its Q1 earnings results on Friday, February 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Earnings Scheduled For February 4, 2022
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter. 
Via Benzinga
Earnings Preview: Meridian Bioscience
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Meridian... 
Via Benzinga
Cannabis Stock Gainers And Losers From February 1, 2022
GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16 
Via Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
Cannabis Stock Gainers And Losers From January 28, 2022
GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33 
Via Benzinga
Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript
VIVO earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Meridian Bioscience's Q4 Earnings Beat Expectations
Meridian Bioscience Inc (NASDAQ: VIVO) posted Q4 sales of $76.2 million, up 19% Y/Y, beating the consensus of $68.40 million. Diagnostics segment net revenues increased... 
Via Benzinga
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.